Aurora's VERSA 110 workstation provides an automated platform for carrying out applications for preparing protein crystallography plates, such as:
• Plate reformatting • Filling plates with polyethylene glycol (PEG) solution • Serial dilutions • Quick dispensing of salt solutions
Automated, software controlled serial dilution options enable the user to configure a precise gradient of conditions by automatically calculating the required concentration of buffer, salts and precipitants to be dispensed into crystallization plates. High throughput screening protocols are supported by Aurora’s user friendly VERSAware interface, further reducing the potential for human error. Methods may be saved, and imported or exported as required. A library of built-in plate types in the software allows the user to select their desired plate format, providing flexibility for all laboratories.
The customizable and versatile nature of the VERSA 110 automated liquid handling workstation software make this instrument suitable for front-end protein crystallization protocols such as sitting drop vapour diffusion protocols, hanging drop vapour diffusion protocols and micro-batch protocols. Aurora’s VERSA 110 liquid handling workstation ensures that high throughput screening of test conditions is accomplished quickly and reliably. This results in the production of more diffractable crystals and improves laboratory productivity.
Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.Therapeutic Approach Gives Hope for Multiple Myeloma A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Genomic Signature Shared by Five Types of Cancer National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. Protein Protects Against Flu in Mice The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.Cat Stem Cell Therapy Gives Humans Hope By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives. Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.